Table 2. Perioperative outcomes.
| Epoch | 2005–2010 ( N = 20) | 2011–2015 ( N = 23) |
2016–2020 ( N = 23) | Significance | ||
|---|---|---|---|---|---|---|
| Extent of resection | STR | 16 (24.2%) | 9 (45.0%) | 3 (13.0%) | 4 (17.4%) | 0.042 |
| NTR | 19 (28.7%) | 7 (35.0%) | 5 (21.7%) | 7 (30.4%) | ||
| GTR | 31 (46.9%) | 4 (20%) | 15 (65.2%) | 12 (52.2%) | ||
| Vision a | Stable | 11 (20%) | 1 (6.3%) | 4 (19%) | 6 (33%) b | 0.264 |
| Improved | 42 (76%) | 14 (87.5%) | 17 (81%) | 11 (61.1%) | ||
| Worsened | 2 (3.6%) | 1 (6.3%) | 0 (0%) | 1 (5.6%) | ||
| Complication | New hydrocephalus | 6 (9.1%) | 4 (20%) | 1 (4.3%) | 1 (4.3%) | 0.127 |
| Meningitis | 2 (3.0%) | 2 (10%) | 0 | 0 | – | |
| Postoperative CSF leak | 9 (13.6%) | 8 (40%) | 1 (4.5%) | 0 (0) | 0.0001 | |
| Hyponatremia | 5 (7.6 %) | 0 | 1 (4.3%) | 4 (17.4%) | 0.076 | |
| Seizure | 1 (1.5%) | 0 | 1 (4.3%) | 0 | – | |
| Rhinological complication c | 9 (13.6%) | 2 (10%) | 4(17.4%) | 3 (13%) | 0.824 | |
| Carotid artery injury | 1 (1.5%) | 1 (5%) | 0 | 0 | – | |
| Stroke | 1 (1.5%) | 1 (5%) | 0 | 0 | – | |
| Median LOS | 6 (2–115) | 6 | 6 | 4 | 0.03 | |
| Discharge status | Home | 51 (86%) | 9 (45%) | 21 (95.7%) | 21 (91.3%) | 0.001 |
| Rehab or NSF | 8 (14%) | 5 (25%) | 1 (4.3%) | 2 (8.7%) |
Abbreviations: CSF, cerebrospinal fluid; GTR, gross total resection; LOS, length of stay; NTR, near total resection; STR, subtotal resection.
a
Eleven patients without vision assessment.
b
Six patients in the latest cohort without preoperative vision deficits who remained stable on postoperative assessment.
c
Epistaxis ( n = 1), anterior septal perforation ( n = 4), sinusitis ( n = 3), and saddle nose deformity ( n = 1). Bold values indicate significant level less than 0.05.